No evidence for an association between Saitohin Q7R polymorphism and Alzheimer's disease [2]

Annals of Neurology

Volumn 52, Issue 5, 2002, Pages 690-691

  Cook, Lynnette ^a   Brayne, Carol E ^b   Easton, Douglas ^c   Evans, John Grimley ^d   Xuereb, John ^c   Cairns, Nigel J ^e   Rubinsztein, David C ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b Institute of Public Health   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d RADCLIFFE INFIRMARY   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; SAITOHIN PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0036828831     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10362     Document Type: Letter

References (5)

1. Conrad C, Vianna C, Freeman M, Davies P. A polymorphic gene nested within an intron of the tau gene: Implications for Alzheimer's disease. Proc Natl Acad Sci USA 2002;99: 7751-7756.
2. Rubinsztein DC, Easton DF. Apolipoprotein E genetic variation and Alzheimer's disease: A meta-analysis. Dement Geriatr Cogn Disord 1999;10:199-209.
3. MRC CFAS. Cognitive function and dementia in six areas of England and Wales: The distribution of MMSE and prevalence of GMS organicity level in the MRC CFA Study. Psychol Med 1999;28:319-335.
4. Paykel ES, Brayne C, Huppert F, et al. Incidence of dementia in a population older than 75 years in the United Kingdom. Arch Gen Psychiatry 1994;51:325-332.
5. Narain Y, Yip A, Murphy T, et al. The ACE gene and Alzheimer disease susceptibility. J Med Genet 2000;37:695-769.